FDA Approved: TASCENSO ODT — Original Application (Cycle Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved TASCENSO ODT, an oral disintegrating tablet containing fingolimod lauryl sulfate, under an original application by Cycle Pharmaceuticals Ltd, f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)

Snippet

ORIG AP for TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)